Sun Nuclear Corporation announced today its PerFRACTION™ patient-specific quality assurance (QA) software has been selected for deployment by Genesis CancerCare, Australia’s largest radiation oncology provider with more than 300,000 patients treated annually at 25 clinics nationwide. PerFRACTION is a module within the SunCHECK™ radiation therapy quality management platform, and is exclusively distributed in Australia and New Zealand by alphaXRT.Read More
Accuray Incorporated (NASDAQ: ARAY) announced today that it has signed a distributor agreement with alphaXRT involving the CyberKnife® and TomoTherapy® System portfolios in Australia and New Zealand. Under the terms of the agreement, alphaXRT will be the sole distributor for Accuray products in these territories.Read More
The inaugural Australasian RayStation Symposium, hosted by alphaXRT and Radiation Oncology Institute, was held on Saturday at the Four Seasons in Sydney.
Quality presentations, enthusiastic delegates and our special guest Dr Johan Löf, the Founder and CEO of RaySearch, who shared his vision of the future of radiotherapy, combined to make the day extremely memorable and a great success.Read More
ProNova Solutions, a leading manufacturer of next generation proton therapy equipment, has signed an exclusive agreement with AlphaXRT to represent ProNova’s innovative treatment solution throughout Australia and New Zealand.Read More
Company name of CMS alphatech changed to alphaXRTRead More